It has been a mixed year for Kodiak Sciences Inc. insiders: $217 million bought by four people and $2.2 million sold by one, so more buying than selling overall.
The largest purchase came from Baker Brothers Life Sciences LP (Director), about $55 million.
On the institutional side, 200 funds reported holding KOD at the end of Q2 2026, and more funds bought than sold. Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 667, L.P. | Director | Buy | 1,416 | $85.89 | $122K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 186 | $86.72 | $16K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 3,114 | $86.72 | $270K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 957 | $86.81 | $83K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 16,036 | $86.81 | $1.4M | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 3,790 | $86.94 | $330K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 63,539 | $86.94 | $5.5M | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 4,485 | $87.51 | $392K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 75,176 | $87.51 | $6.6M | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 5,880 | $88.57 | $521K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 98,561 | $88.57 | $8.7M | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 6,428 | $88.65 | $570K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 107,772 | $88.65 | $9.6M | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 4,932 | $89.60 | $442K | SEC |
| Sep 30, 2026 | 667, L.P. | Director | Buy | 82,673 | $89.60 | $7.4M | SEC |
In the last 12 months Kodiak Sciences Inc. insiders made open-market purchases worth about $217 million and sales worth about $2.2 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in KOD was filed on 2026-09-30.
200 investment managers reported holding KOD in SEC Form 13F filings for Q2 2026.
No congressional trades in KOD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).